CACI Denies Use of Torture in Iraq

CACI International, an Arlington-based provider of interrogators to the U.S. military in Iraq, said it “rejects and denies” allegations from four Iraqi men who said they were tortured at Abu Ghraib prison. The “unfounded” claims filed in lawsuits are a “rehash of the previous slanderous lawsuits,” CACI said in a statement. Similar lawsuits filed in the past four years await trial.

The four men say contractors hired by CACI and L-3 Communications Holdings beat and humiliated prisoners.



Dominion Wants to Build Reactor

Energy company Dominion Resources, based in Richmond, hopes to have a new nuclear reactor online by 2016, which would make it the nation’s first new reactor since 1996.

Dominion hopes to build a third reactor at its North Anna Power Station, Thomas F. Farrell II, Dominion chairman, president and chief executive, said during an interview Monday on CNBC‘s “Squawk Box.”

In November, the company filed an application for a combined operating license with the U.S. Nuclear Regulatory Commission for the additional reactor. Federal regulators have approved an early site permit for the reactor at the plant, about 60 miles north of Richmond.

Dominion has said new a reactor would create 750 permanent jobs and thousands of jobs during the four-year construction process. It also could generate electricity to power 375,000 homes at peak demands.



D.C. Firm to Open in Abu Dhabi

Hogan & Hartson, a law firm based in the District, said it is opening an office in Abu Dhabi in the United Arab Emirates, its first in the Middle East. Partner Ray Batla will be managing partner of the office, the firm’s 25th.

“We have been increasingly focused on this region and this move further demonstrates our commitment to the Middle East practice,” Chairman J. Warren Gorrell said.


Emergent BioSolutions, a Rockville maker of the only U.S.-approved anthrax vaccine, said its acquisition of Protein Sciences, developer of the flu vaccine FluBlok, has been delayed.

Closely held Protein Sciences postponed a vote on the sale because of a “procedural defect” in its shareholder meeting, Emergent said. Emergent had expected the deal to be completed Monday.

FluBlok, a genetically engineered flu vaccine, may be close to winning U.S. approval and would compete with shots made by Sanofi-Aventis and GlaxoSmithKline. The Protein Science technology produces flu proteins in caterpillar cells.



Carlyle, Extell Plan NYC Towers

The Carlyle Group, Extell Development and RREEF Alternative Investments got $613 million in financing for two luxury residential buildings on Manhattan’s Upper West Side, the largest construction loan this year.

Deutsche Bank led a group of nine banks arranging the loan, the companies said. The properties are being developed at West 62nd and West 63rd streets at Riverside Boulevard on a 13-acre plot called Riverside South.

Developers have struggled to finance new projects as banks curtail lending following the collapse of the subprime mortgage market. Manhattan luxury apartment prices are rising even as values drop nationally.

Compiled from reports by Washington Post staff writers, Associated Press and Bloomberg.